Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Radhakrishnan Anup | See Remarks | 14 | $0 | $159.0K | 2025-08-19 |
| Viswanadhan Krishnan | Director | 5 | $0 | $0 | 2025-08-19 |
| Bassan Abraham | Director | 4 | $0 | $0 | 2025-08-19 |
| Huber Reid M | Director | 4 | $0 | $0 | 2025-08-19 |
| Lubner David Charles | Director | 4 | $0 | $0 | 2025-08-19 |
| Orwin John A | Director | 5 | $0 | $0 | 2025-08-19 |
| Dhingra Kapil | Director | 4 | $0 | $0 | 2025-08-19 |
| Henderson Jane | Director | 4 | $0 | $0 | 2025-08-19 |
| Laport Ginna | Chief Medical Officer | 2 | $0 | $0 | 2025-03-14 |
| Gadam Shishir | Chief Technical Officer | 2 | $0 | $0 | 2025-03-14 |
| Chapman Gina | President & CEO | 8 | $0 | $254.3K | 2025-03-14 |
| Samsara BioCapital, L.P. | 10% Owner | 1 | $5.00M | $0 | 2024-05-30 |
| RTW INVESTMENTS, LP | 10% Owner | 1 | $0 | $0 | 2024-01-12 |
| TRV GP V, LLC | 10% Owner | 5 | $20.00M | $0 | 2023-11-14 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | 2 | $0 | $0 | 2023-11-14 |
| AKKARAJU SRINIVAS | 10% Owner | 5 | $10.00M | $0 | 2023-11-14 |
| EDELMAN JOSEPH | Other | 4 | $10.00M | $0 | 2023-11-14 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Radhakrishnan Anup | See Remarks | D To issuer deriv | 2025-08-19 | 2025-08-19 | 14,679 | — | $0 | 0 | SEC↗ |
| Huber Reid M | Director | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| Bassan Abraham | Director | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Director | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| Orwin John A | Director | D To issuer deriv | 2025-08-19 | 2025-08-19 | 15,865 | — | $0 | 0 | SEC↗ |
| Orwin John A | Director | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| Lubner David Charles | Director | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| Viswanadhan Krishnan | Director | D To issuer deriv | 2025-08-19 | 2025-08-19 | 3,173 | — | $0 | 0 | SEC↗ |
| Viswanadhan Krishnan | Director | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| Dhingra Kapil | Director | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| Radhakrishnan Anup | See Remarks | D To issuer | 2025-08-19 | 2025-08-19 | 63,436 | $4.38 | $277.8K | 0 | SEC↗ |
| Radhakrishnan Anup | See Remarks | U Tender | 2025-08-18 | 2025-08-19 | 57,345 | $4.38 | $251.2K | 63,436 | SEC↗ |
| Radhakrishnan Anup | See Remarks | S Sale | 2025-07-02 | 2025-07-03 | 1,632 | $4.18 | $6.8K | 120,781 | SEC↗ |
| Orwin John A | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Henderson Jane | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Dhingra Kapil | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Bassan Abraham | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Huber Reid M | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Viswanadhan Krishnan | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Radhakrishnan Anup | See Remarks | S Sale | 2025-05-14 | 2025-05-16 | 27,404 | $3.84 | $105.2K | 122,413 | SEC↗ |
| Radhakrishnan Anup | See Remarks | A Award | 2025-05-12 | 2025-05-14 | 72,500 | — | $0 | 149,817 | SEC↗ |
| Radhakrishnan Anup | See Remarks | S Sale | 2025-04-03 | 2025-04-08 | 1,629 | $4.00 | $6.5K | 77,317 | SEC↗ |
| Gadam Shishir | Chief Technical Officer | A Award | 2025-03-14 | 2025-03-18 | 60,000 | — | $0 | 89,480 | SEC↗ |
| Chapman Gina | President & CEO | A Award | 2025-03-14 | 2025-03-18 | 200,000 | — | $0 | 303,905 | SEC↗ |
| Laport Ginna | Chief Medical Officer | A Award | 2025-03-14 | 2025-03-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Radhakrishnan Anup | See Remarks | A Award | 2025-03-14 | 2025-03-18 | 72,500 | — | $0 | 78,946 | SEC↗ |
| Radhakrishnan Anup | See Remarks | A Award deriv | 2024-11-15 | 2024-11-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Chapman Gina | President & CEO | M Exercise deriv | 2024-09-19 | 2024-09-20 | 2,975 | — | $0 | 549,515 | SEC↗ |
| Chapman Gina | President & CEO | S Sale | 2024-09-19 | 2024-09-20 | 2,975 | $25.03 | $74.5K | 103,905 | SEC↗ |
| Chapman Gina | President & CEO | M Exercise | 2024-09-19 | 2024-09-20 | 2,975 | $5.03 | $15.0K | 106,880 | SEC↗ |
| Radhakrishnan Anup | Chief Financial Officer | M Exercise deriv | 2024-09-18 | 2024-09-20 | 1,600 | — | $0 | 53,180 | SEC↗ |
| Chapman Gina | President & CEO | M Exercise deriv | 2024-09-18 | 2024-09-20 | 7,166 | — | $0 | 552,490 | SEC↗ |
| Radhakrishnan Anup | Chief Financial Officer | S Sale | 2024-09-18 | 2024-09-20 | 1,600 | $25.28 | $40.4K | 6,446 | SEC↗ |
| Radhakrishnan Anup | Chief Financial Officer | M Exercise | 2024-09-18 | 2024-09-20 | 1,600 | $5.03 | $8.0K | 8,046 | SEC↗ |
| Chapman Gina | President & CEO | M Exercise | 2024-09-18 | 2024-09-20 | 7,166 | $5.03 | $36.0K | 111,071 | SEC↗ |
| Chapman Gina | President & CEO | S Sale | 2024-09-18 | 2024-09-20 | 7,166 | $25.09 | $179.8K | 103,905 | SEC↗ |
| Henderson Jane | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 39,402 | — | $0 | 39,402 | SEC↗ |
| Henderson Jane | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 19,785 | — | $0 | 19,785 | SEC↗ |
| Orwin John A | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 23,742 | — | $0 | 23,742 | SEC↗ |
| Huber Reid M | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 23,742 | — | $0 | 23,742 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 23,742 | — | $0 | 23,742 | SEC↗ |
| Viswanadhan Krishnan | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 23,742 | — | $0 | 23,742 | SEC↗ |
| Bassan Abraham | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 23,742 | — | $0 | 23,742 | SEC↗ |
| Dhingra Kapil | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 11,871 | — | $0 | 11,871 | SEC↗ |
| Samsara BioCapital, L.P. | 10% Owner | P Buy | 2024-05-30 | 2024-06-03 | 294,000 | $17.00 | $5.00M | 4,415,689 | SEC↗ |
| Dhingra Kapil | Director | A Award deriv | 2024-04-15 | 2024-04-17 | 49,265 | — | $0 | 49,265 | SEC↗ |
| Chapman Gina | President & CEO | A Award deriv | 2024-03-01 | 2024-03-04 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Radhakrishnan Anup | Chief Financial Officer | A Award deriv | 2024-03-01 | 2024-03-04 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Gadam Shishir | Chief Technical Officer | A Award deriv | 2024-03-01 | 2024-03-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Laport Ginna | Chief Medical Officer | A Award deriv | 2024-03-01 | 2024-03-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RTW INVESTMENTS, LP | 10% Owner | J Other | 2024-01-12 | 2024-01-16 | 1,842,499 | — | $0 | 5,175,832 | SEC↗ |
| EDELMAN JOSEPH | Other | C Conversion deriv | 2023-11-14 | 2023-11-14 | 2,579,502 | — | $0 | 0 | SEC↗ |
| TRV GP V, LLC | 10% Owner | C Conversion deriv | 2023-11-14 | 2023-11-14 | 23,571,429 | — | $0 | 0 | SEC↗ |
| TRV GP V, LLC | 10% Owner | C Conversion deriv | 2023-11-14 | 2023-11-14 | 6,428,571 | — | $0 | 0 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion deriv | 2023-11-14 | 2023-11-16 | 10,000,000 | — | $0 | 0 | SEC↗ |
| AKKARAJU SRINIVAS | 10% Owner | C Conversion deriv | 2023-11-14 | 2023-11-16 | 884,400 | — | $0 | 0 | SEC↗ |
| AKKARAJU SRINIVAS | 10% Owner | C Conversion deriv | 2023-11-14 | 2023-11-16 | 663,300 | — | $0 | 0 | SEC↗ |
| AKKARAJU SRINIVAS | 10% Owner | C Conversion deriv | 2023-11-14 | 2023-11-16 | 1,833,623 | — | $0 | 0 | SEC↗ |
| EDELMAN JOSEPH | Other | C Conversion | 2023-11-14 | 2023-11-14 | 2,579,502 | — | $0 | 2,579,502 | SEC↗ |
| EDELMAN JOSEPH | Other | P Buy | 2023-11-14 | 2023-11-14 | 333,333 | $15.00 | $5.00M | 333,333 | SEC↗ |
| EDELMAN JOSEPH | Other | P Buy | 2023-11-14 | 2023-11-14 | 333,333 | $15.00 | $5.00M | 2,912,835 | SEC↗ |
| TRV GP V, LLC | 10% Owner | C Conversion | 2023-11-14 | 2023-11-14 | 1,737,216 | — | $0 | 1,737,216 | SEC↗ |
| TRV GP V, LLC | 10% Owner | P Buy | 2023-11-14 | 2023-11-14 | 1,333,333 | $15.00 | $20.00M | 1,807,119 | SEC↗ |
| TRV GP V, LLC | 10% Owner | C Conversion | 2023-11-14 | 2023-11-14 | 473,786 | — | $0 | 473,786 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion | 2023-11-14 | 2023-11-16 | 737,000 | — | $0 | 737,000 | SEC↗ |
| AKKARAJU SRINIVAS | 10% Owner | C Conversion | 2023-11-14 | 2023-11-16 | 3,381,323 | — | $0 | 3,455,023 | SEC↗ |
| AKKARAJU SRINIVAS | 10% Owner | P Buy | 2023-11-14 | 2023-11-16 | 666,666 | $15.00 | $10.00M | 4,121,689 | SEC↗ |
| Bassan Abraham | Director | A Award deriv | 2023-11-09 | 2023-11-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Huber Reid M | Director | A Award deriv | 2023-11-09 | 2023-11-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Viswanadhan Krishnan | Director | A Award deriv | 2023-11-09 | 2023-11-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Orwin John A | Director | A Award deriv | 2023-11-09 | 2023-11-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2023-11-09 | 2023-11-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Radhakrishnan Anup | Chief Financial Officer | A Award deriv | 2023-11-09 | 2023-11-13 | 100,000 | — | $0 | 100,000 | SEC↗ |